ZURA BIO LIMITED Weighted Average Number of Shares Outstanding, Basic and Diluted
ZURA BIO LIMITED (ZURA) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 3.45 million shares for the 1-month period ending 2021-03-31, per its 10-Q filed 2021-08-27.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-08-27
- 2021-03-31: Weighted Average Number of Shares Outstanding, Basic and Diluted 1 month 3.45M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 1 month |
|---|---|
| 2021-03-31 | 3.45M shares 10-Q · filed 2021-08-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |